CD40 Gene: Structure, Function, and Clinical Significance
A comprehensive overview of the CD40 gene, its protein product, associated diseases, expression patterns, and mutations.
Gene Information Card
| Symbol | CD40 |
|---|---|
| Full Name | CD40 molecule |
| Gene Type | protein-coding |
| Chromosomal Location | 20q13.12 |
| NCBI Gene ID | 958 ncbi.nlm.nih.gov/gene/958 |
| Ensembl ID | ENSG00000101017 |
| UniProt ID | P25942 |
| OMIM ID | 109535 |
| HGNC ID | 11919 |
| Aliases | TNFRSF5, p50, Bp50, CDW40 |
Description
The CD40 gene encodes a member of the tumor necrosis factor receptor superfamily. This transmembrane protein is expressed on various immune cells, including B cells, dendritic cells, and macrophages, as well as on non-immune cells like endothelial and epithelial cells. CD40 plays a critical role in mediating immune responses, including B cell activation, immunoglobulin class switching, and T cell-dependent humoral immunity. It also participates in inflammatory responses and has been implicated in various cancers and autoimmune diseases.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Hyper-IgM syndrome type 3 | Mutations in CD40 lead to defective CD40-CD40L interaction, impairing B cell class switching and somatic hypermutation. | OMIM, ClinVar |
| Multiple myeloma | CD40 signaling promotes tumor cell survival and proliferation in multiple myeloma. | COSMIC, PubMed |
| Atherosclerosis | CD40-CD40L interaction contributes to vascular inflammation and plaque formation. | PubMed |
| Systemic lupus erythematosus (SLE) | CD40 activation on B cells enhances autoantibody production. | PubMed |
| Lymphoma | CD40 mutations and overexpression are observed in various lymphomas, contributing to tumor growth. | COSMIC |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Blood | 12.5 | Medium |
| Spleen | 10.2 | Medium |
| Lymph node | 9.8 | Medium |
| Bone marrow | 8.1 | Low |
| Lung | 4.3 | Low |
| Liver | 2.1 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| B cells | 25.0 | High expression |
| Dendritic cells | 20.0 | High expression |
| Macrophages | 15.0 | Medium expression |
| Endothelial cells | 8.0 | Low expression |
| Epithelial cells | 5.0 | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.481C>T (p.Arg161Ter) | Nonsense | Rare | Loss of function, leads to truncated protein |
| c.590A>G (p.Asn197Ser) | Missense | Rare | Impaired ligand binding |
| c.682G>A (p.Gly228Arg) | Missense | Rare | Disrupts protein folding |
| c.784C>T (p.Arg262Trp) | Missense | Rare | Reduced cell surface expression |
Mutation functional classification
Loss of Function (LOF)
Mutations that impair CD40 expression or ligand binding lead to loss of function, resulting in immunodeficiency, particularly hyper-IgM syndrome.
Gain of Function (GOF)
Gain-of-function mutations are rare but may lead to constitutive activation, contributing to oncogenic signaling in some cancers.
Dominant Negative (DN)
Some missense mutations may exert dominant-negative effects by forming non-functional oligomers with wild-type CD40.
View complete mutation data:
Gene Ontology (GO)
| • receptor activity | • protein binding |
| • signal transduction | • immune response |
| • apoptotic process | • cell surface receptor signaling pathway |
Pathways
• CD40/CD40L signaling pathway
• NF-kappa B signaling pathway
• T cell receptor signaling pathway
• B cell receptor signaling pathway
Protein Summary
The CD40 protein is a type I transmembrane glycoprotein of 277 amino acids. It consists of an extracellular domain with four cysteine-rich repeats, a single transmembrane domain, and a cytoplasmic tail that lacks intrinsic kinase activity but recruits TRAF proteins to activate downstream signaling pathways. CD40 is expressed on antigen-presenting cells and interacts with its ligand CD40L (CD154) on T cells, leading to activation of NF-κB, MAPK, and PI3K pathways. This results in upregulation of costimulatory molecules, cytokine production, and immunoglobulin class switching. CD40 also plays a role in cell survival and apoptosis depending on cellular context.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CD40 Knockout HEK293 Cell Line | EDJ-KQ553 | Human | 958 | Details Get a Quote |
| CD40LG Knockout HEK293 Cell Line | EDJ-KQ554 | Human | 959 | Details Get a Quote |
| CD40 Knockout A-549 Cell Line | EDJ-KQ18027 | Human | 958 | Details Get a Quote |
| CD40 Knockout HCT 116 Cell Line | EDJ-KQ18925 | Human | 958 | Details Get a Quote |
| CD40 Knockout HeLa Cell Line | EDJ-KQ52841 | Human | 958 | Details Get a Quote |
| CD40LG Knockout HeLa Cell Line | EDJ-KQ52842 | Human | 959 | Details Get a Quote |
| CD40LG Knockout A-549 Cell Line | EDJ-KQ61309 | Human | 959 | Details Get a Quote |
| CD40LG Knockout HCT 116 Cell Line | EDJ-KQ69803 | Human | 959 | Details Get a Quote |
Displaying Records 1 To 8 Of 8 Records